4.2 Article

ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer

Related references

Note: Only part of the references are listed.
Review Immunology

Metabolic adaptation of lymphocytes in immunity and disease

Nicole M. Chapman et al.

Summary: Adaptive immune responses mediated by T cells and B cells are crucial for protective immunity against pathogens and tumors. Understanding how metabolic plasticity and adaptation dictate functional specialization of immune cells is fundamental to our understanding and therapeutic modulation of the immune system. Extensive progress has been made in characterizing the effects of metabolic networks on immune cell fate and function in different immunological contexts.

IMMUNITY (2022)

Review Cell Biology

Metabolic regulation of somatic stem cells in vivo

Corbin E. Meacham et al.

Summary: The metabolism of somatic stem cells plays a crucial role in their long-term maintenance, activation, proliferation, and differentiation. Understanding the metabolic regulation in stem cells can lead to new opportunities in manipulating their functions, which can have applications in tissue regeneration and cancer prevention. Recent evidence suggests that stem cells have distinct metabolic characteristics compared to restricted progenitors and that metabolic changes influence tissue homeostasis and regeneration. Stem cell metabolism is influenced by the microenvironment and can interact with other cells in their niches.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Oncology

Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics

Dolly Sharma et al.

Summary: Lactate dehydrogenase plays a crucial role in tumor metabolism, and its inhibition may be a potential approach for anticancer therapy.

SEMINARS IN CANCER BIOLOGY (2022)

Article Oncology

Tumor glycolysis, an essential sweet tooth of tumor cells

Sumana Paul et al.

Summary: Cancer cells undergo metabolic alterations to meet energy demands, with glycolysis playing a central role. Glycolysis is intertwined with other metabolic pathways, leading to diverse and heterogeneous cancer metabolism. Oncogenic signaling enhances glycolytic enzyme activity, promoting tumor growth and metastasis. This article discusses the interactions between tumor glycolysis and other metabolic pathways, the role and regulation of key enzymes, and the significance of lactate in tumor growth and metastasis.

SEMINARS IN CANCER BIOLOGY (2022)

Review Pharmacology & Pharmacy

Impact of cancer metabolism on therapy resistance - Clinical implications

Ana Cristina Goncalves et al.

Summary: Despite advancements in cancer therapies, treatment failures and tumor relapses still result in poor outcomes for many patients. Resistance mechanisms, including mutation-driven and tumor microenvironment-induced phenotypic heterogeneity, play a crucial role in limiting the effectiveness of anticancer treatments. Tumor cell metabolism is a key factor in adaptive resistance, allowing cancer cells to survive, metastasize, and develop resistance to therapies.

DRUG RESISTANCE UPDATES (2021)

Article Multidisciplinary Sciences

Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity

Ke Xu et al.

Summary: The passage discusses the impact of infection on T cell immune response, highlighting the crucial role of glycolytic enzyme LDHA in regulating the PI3K-Akt-Foxo1 signaling pathway, a mechanism that serves as a key factor in controlling T cell immunity.

SCIENCE (2021)

Review Oncology

Treatment landscape of metastatic pancreatic cancer

Sara De Dosso et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis. Early diagnosis is challenging due to lack of symptoms, and treatment options include FOLFIRINOX and gemcitabine plus nab-paclitaxel depending on patient characteristics. The lack of molecular and genetic biomarkers hinders optimal patient stratification and treatment decisions, highlighting the need for further research on predictive and prognostic biomarkers and novel treatment strategies to improve outcomes for metastatic pancreatic cancer patients.

CANCER TREATMENT REVIEWS (2021)

Review Gastroenterology & Hepatology

Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors

Alison P. Klein

Summary: Pancreatic cancer is a leading cause of cancer death globally, with significant risk factors including smoking, obesity, diabetes, and genetic factors. Efforts to understand and address these modifiable and inherited risk factors are crucial for early detection and prevention strategies for pancreatic cancer.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Antibody therapy in pancreatic cancer: mAb-ye we're onto something?

Anna J. Boland et al.

Summary: Although antibody therapy for pancreatic cancer has not yet achieved significant success, lessons learned from current research indicate potential future directions for overcoming observed hurdles to achieve clinically efficacious results.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Review Oncology

Cancer metabolism: looking forward

Inmaculada Martinez-Reyes et al.

Summary: This Perspective discusses the main themes in cancer metabolism research, focusing on the relationship between tumour initiation and progression with metabolic reprogramming, as well as the importance of tumor microenvironment and metabolic regulation.

NATURE REVIEWS CANCER (2021)

Review Immunology

Metabolic barriers to cancer immunotherapy

Kristin DePeaux et al.

Summary: The tumour microenvironment creates barriers that suppress immune responses, including physical barriers, recruitment of suppressive immune cells, and upregulation of inhibitory ligands on tumour cells. Therapies targeting metabolic restrictions in the tumour microenvironment show promise for combination therapies against various types of cancer.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Oncology

The metabolism of cancer cells during metastasis

Gabriele Bergers et al.

Summary: This review discusses the metabolic rewiring in cancer cells during the metastatic cascade and the distinct metabolic features of primary tumors and metastases. Metastasis is the leading cause of death in most cancer patients, and targeting metastatic seeding and colonization remains a significant challenge. Adjusting metabolism may provide therapeutic opportunities to prevent or reduce metastasis, and targeting the new metabolic traits in established metastases could lead to their eradication.

NATURE REVIEWS CANCER (2021)

Review Biochemistry & Molecular Biology

Metabolism of pancreatic cancer: paving the way to better anticancer strategies

Cheng Qin et al.

MOLECULAR CANCER (2020)

Review Pharmacology & Pharmacy

New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma

Ritu Raj Singh et al.

DRUGS (2020)

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

Review Oncology

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Yunzhen Qian et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Editorial Material Biochemistry & Molecular Biology

Cutting out the fat: Site-specific deacylation of an ion channel

Pedro J. del Rivero Morfin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Review Gastroenterology & Hepatology

Molecular subtypes of pancreatic cancer

Eric A. Collisson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Biotechnology & Applied Microbiology

Targeting metabolism to regulate immune responses in autoimmunity and cancer

Chirag H. Patel et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Gastroenterology & Hepatology

Therapeutic developments in pancreatic cancer: current and future perspectives

John P. Neoptolemos et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Oncology

Cancer Statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Review Oncology

PD-1/PD-L1 and immunotherapy for pancreatic cancer

Mengyu Feng et al.

CANCER LETTERS (2017)

Review Cell Biology

Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy

Rigel J. Kishton et al.

CELL METABOLISM (2017)

Review Oncology

Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer

Christopher J. Habrook et al.

CANCER CELL (2017)

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Review Multidisciplinary Sciences

Fundamentals of cancer metabolism

Ralph J. DeBerardinis et al.

SCIENCE ADVANCES (2016)

Review Biochemical Research Methods

How metabolites modulate metabolic flux

Andre Wegner et al.

CURRENT OPINION IN BIOTECHNOLOGY (2015)

Review Medicine, Research & Experimental

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations

Gregg L. Semenza

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Cell Biology

Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation

Sophia Y. Lunt et al.

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)

Article Medicine, General & Internal

Pancreatic cancer

Audrey Vincent et al.

LANCET (2011)

Review Oncology

Otto Warburg's contributions to current concepts of cancer metabolism

Willem H. Koppenol et al.

NATURE REVIEWS CANCER (2011)